Donafenib tosylate clinical trials
A product of Donafenib; its studies count on that page too.
How each study uses donafenib tosylate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the donafenib tosylate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 1
Suzhou Zelgen Biopharmaceuticals Co.,Ltd (5) · Changsha Taihe Hospital (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Donafenib
Studies
Open first, then newest update. How each study uses donafenib tosylate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNot applicableChangsha Taihe HospitalNCT06233994Written as Donafenib Tosilate TabletsHow we know
- A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal TumorsTerminatedPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04612712Written as Donafenib Tosilate TabletsHow we know
- A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid TumorStatus unknownPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT06239298Written as Donafenib Tosilate TabletsHow we know
- A Study of Donafenib Monotherapy in Advanced Oesophageal CancerTerminatedPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT02489201Written as donafenib tosilate tabletsHow we know
- Donafenib Monotherapy for Previously Treated Metastatic Gastric CancerTerminatedPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT02489214Written as donafenib tosilate tabletsHow we know
- Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownPhase 1/2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04503902Written as Donafenib Tosilate TabletsHow we know